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Abstract  
Introduction: Antimicrobial prophylaxis for urologic procedures is a major issue, as potential advantages of antibiotic administration should be 
carefully weighed against potential side effects, microbial resistance, and health care costs. This study aimed to review a six years trend of 
antibiotic use in urological surgeries at Muhimbili National Hospital (MNH) being an experience in a typical third world environment. Methods: This 
was a six years hospital based descriptive, retrospective study conducted of which all case notes of urological patients operated on in between 
January 2007 to December, 2012 were reviewed by using a structured data collecting tool. The data were analyzed using SPSS software. Results: 
Male patients were the majority at 62% (450). The age range was 0 - 90 years, with a mean of 30 ± 22.09. Among the urological surgeries done 
at MNH 86.5% (628) received prophylactic antibiotics regardless of the type surgery done. Majority 63.7% (463) received antibiotics during 
induction. Ceftriaxone was the commonly given antibiotic regardless of the type of urological surgery done. Most of patients (86.4%) were given 
antibiotics for five days regardless whether it was for prophylactic or treatment intention. Conclusion: Antibiotic use is still a challenge at our 
hospital with over use of prophylactic antibiotics without obvious indications. Prolonged use of prophylactic antibiotics beyond five days was the 
main finding. Ceftriaxone was the most given antibiotic regardless of the urological surgery done and its level of contamination. Antibiotic 
stewardship needs to be addressed urgently to avoid serious drug resistances leaving alone the cost implication.  
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Antibiotics are synthetic molecules that can destroy or inhibit the 
growth of microorganisms without harming the host. They can be 
used for prophylactic purposes to reduce the incidence of 
postoperative infection of which duration should not exceed 24hrs in 
many procedures given one hour prior to incision. Also antibiotics 
for treatment purposes are given when an established infection has 
been identified.Antibiotic prophylaxis is a brief course of antibiotics 
administered before or at the start of an intervention and used to 
minimize the infectious complications resulting from diagnostic and 
therapeutic interventions. While the rationale for the use of 
antibiotics is well accepted, possible side-effects and development 
of microbial resistance patterns are potential risks. Therefore, an 
antibiotic prophylaxis policy should be well considered and, ideally, 
based on high levels of evidence. Urology is a surgical speciality 
which has under-gone many changes in the last decade. Surgical 
procedures have mainly shifted from open to endoscopic and 
laparoscopic procedures, and nowadays, a greater number of 
elderly patients or carriers of temporary urinary derivations are 
being operated on. These developments can influence the choice of 
antibiotic prophylaxis policy. Although it is common practice to 
administer antibiotic prophylaxis in many urologic procedures, there 
is still little evidence for the use of antibiotic prophylaxis in most of 
these procedures. This is mainly due to the lack of well-designed 
studies as well as the lack of clear definitions of favourable outcome 
parameters. The question remains to what extent antibiotic 
prophylaxis is beneficial in the different urologic procedures. Various 
authors have addressed this issue in reviews in recent years [1-5]. 
Also, the European Association of Urology (EAU) has recently 
updated the guideline "Management of urinary and male genital 
tract infections", including a chapter on perioperative antibacterial 
prophylaxis in urology. However with the exception of the 
transurethral resection of the prostate (TURP) [6-14], some of the 
recommendations in these reviews and guidelines are supported by 
evidence gathered in a structured systematic review. Surgical 
wound classification in the categories clean, clean-contaminated, 
contaminated and dirty seems just as relevant for urologic surgery 
as for general surgery [15-16]. In this way assessing the pre-
intervention surgical wound class, an estimate can be made of the 
need for antibiotic prophylaxis during surgery. Clean surgery 
involves uninfected tissues without opening of the urinary tract and 
with primary closure of the wound. In clean contaminated surgery, 
the urinary tract is entered under controlled conditions, without the 
presence of infected tissues or bacteriuria. Surgery with use of 
bowel tissue is also classified as clean-contaminated. The presence 
of a non treated infection, including UTI, should be considered as 
contaminated urologic surgery. When pus is present, the surgery is 
labelled dirty. Implantation of prosthesis material is not classified as 
above. Since infectious complications are potentially serious when 
involving prosthesis material, antibiotic coverage is advocated 
irrespective of surgical class [2, 12, 16]. Derived from the surgical 
literature and not supported by urologic evidence, there is no 
indication for antibiotic prophylaxis in clean surgery, whereas there 
is an indication in clean-contaminated and prosthetic surgery. 
Contaminated and dirty surgery should be covered by therapeutic 
antibiotics instead of prophylactic dosages. Our study aimed to 
review a six years trend of antibiotic use in urological surgeries at 
Muhimbili National Hospital (MNH) being an experience in a typical 







This was a retrospective study at Muhimbili National Hospital 
(MNH)- medical record department from November 2013 to April 
2014. All case notes of urological patients operated on in between 
January 2007 to December, 2012 was included in the study.  
  
Inclusion criteria  
  
All available case notes of operated patients in urology unit during 
the period of 2007 to 2012 were eligible for use in this study.  
  
Exclusion criteria  
  
Case notes with incomplete information were not considered in 
some of the analysis where such missing variable are imperative.  
  
Data processing and analysis  
  
A structured questionnaire was used to collect data from patient's 
case notes. An electronically generated medical detail of all operated 
patients was obtained per year. The details that were possible to 
obtain included the age, sex, file number, date of operation and 
type of operation. From this, patients who were operated under 
urology unit were identified and their case notes retrieved. Data 
coding was done, cleansed and entered into computer software for 
storage and analysis using SPSS version 18 statistical program. 
Frequencies were run for all categorical variables and patterns of 
surgery and their outcome described. Mean and standard deviation 
were used to summarize continuous variables.  
  
Ethical issues  
  
Ethical clearance to conduct the study was obtained from the 
Institutional Review Board (IRB) at Muhimbili University of Health 
and Allied Sciences (MUHAS) 
REF.No.MU/DRP/AEC/Vol.XVIII/22 of 30th October 2013 
and a separate permission to conduct the study was also obtained 
from the Executive Director of Muhimbili National Hospital (MNH). 
Direct patient identifiers were not used except for file numbers 
during initial data collection; thereafter the questionnaires were 
coded for further analysis.  
  
Study limitations  
  
This study was done at Muhimbili National Hospital which is the only 
national referral hospital located in the Centre of Dar es Salaam city, 
thus the findings may reflect a true image of the trend of antibiotic 
use in urological surgeries in Dar es Salaam and country. At large 





A total 726 case notes of patients who underwent urological 
surgeries during the study period of six years were reviewed. The 
age range was 0 - 90 years, with a mean of 30 ± 22.09 with male 
predominance giving a ratio of 6.4: 1. Cystoscopy 260 (36%) was 
the most commonly done urological surgery followed by 
prostatectomy 154 (21%) (Table 1). Most of our patients 589 
(81.1%) were given antibiotics regardless of the type urological 
surgeries. Eighty seven point four percent of clean contaminated 
urological surgeries were given prophylactic antibiotics also those 
who had clean urological surgeries 265 (74.6%) were given 
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antibiotics. There were neither contaminated nor dirty urological 
surgeries done (Table 2). Majority of our patients 63.7% (463) 
received antibiotics during induction. The commonly given 
antibiotics were Ceftriaxone combined with metronidazole 37.5% 
and ceftriaxone alone was given in 46.1% with Gentamycin being 
given alone in 6% only. Ceftriaxone was the commonly given 






In this study we found that urological surgeries are predominantly 
done in male with a wide range of ages. Most of our patients 589 
(81.1%) were given antibiotics regardless of the type urological 
surgeries this is similar to the findings of others studies in Europe, 
United states and local studies that addresses the use of antibiotic 
prophylaxis in urologic interventions. Contrary to the 
recommendation from others studies that Antibiotics for most 
urologic interventions having only moderate to low evidence for the 
use of antibiotic prophylaxis, with the exception of TURP and 
prostate biopsy. Strong evidence supports the use of short-term 
prophylaxis for TURP, and this evidence is moderate to high for 
prostate biopsy. The main point of consideration when assessing the 
benefit of antibiotic prophylaxis is what to consider as a favourable 
outcome. In our study Eighty seven point four percent of clean 
contaminated urological surgeries were given prophylactic 
antibiotics also those who had clean urological surgeries 265 
(74.6%) were given antibiotics [1, 3-5, 12, 17]. Our study did not 
explore on why patients were given antibiotics uphazardly but 
probably clinicians' thoughts are to decrease of post intervention 
bacteriuria, or decrease of symptomatic UTIs or other infectious 
complications' While the aim of preventing symptomatic UTIs and 
other serious infectious complications seems evident, the need to 
prevent asymptomatic bacteriuria remains questionable. 
Asymptomatic bacteriuria is often of no clinical importance and 
resolves spontaneously in many cases as the findings of other 
studies elsewhere [1, 3-11, 13, 18]. This being a retrospective 
study, we could not asses the outcomes of those patients post 
urological intervention therefore we could not find high evidence 
supporting the use of antibiotic prophylaxis in urologic interventions 
to prevent complications such as UTI including in those who had 
TURP done as it was found out in other studies that no enough 
evidence supports the systematic use of antibiotic prophylaxis to 
prevent UTIs in the rest of the procedures. However, when 
performing case notes review, we realized not only that variations in 
duration, antibiotic agent, or dose of what was considered 
"antibiotic prophylaxis" existed, but also that variables of importance 
in some patients who were discharged with urethral catheters or 
stents were insufficiently explored as those increases the risk of a 
post-operative infectious complication and, therefore, the need for 
an adequate antibiotic prophylaxis even in cases of low evidence for 
benefit. Still, good clinical practice should drive the decision in that 
circumstance [5, 10, 19, 20]. We found that Ceftriaxone was the 
commonly given antibiotic regardless of the type of urological 
surgery done similarly to the findings of other studies whereby 
overuse of third generation cephalosporin was noted, from this 
clinicians should keep in mind that antibiotic prophylaxis is only one 
of the various measures to prevent post-intervention infectious 
complications. Antibiotic prophylaxis cannot compensate for 
inadequate operative care, and, therefore, general 
recommendations for prevention of surgical site infections should be 






Antibiotic use is still a challenge at our hospital. Prolonged use of 
prophylactic antibiotics beyond five days was the main finding. 
Ceftriaxone was the most given antibiotic regardless of the 
urological surgery done and its level of contamination. Antibiotic 
stewardship needs to be addressed by adhering to antibiotics use 
guidelines and this will increase the quality of care and at the same 
time reduce both costs and the development of microbial resistance. 
Further research is needed because of lack of evidence that those 
patients with increased risk for infectious complications should 
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Table 1: The distribution of urological surgeries  
Table 2: Levels of contamination in urological surgeries and 
antibiotic use  
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Table 1: the distribution of urological surgeries  
Procedure Number Percentage 
Cystoscopy 260 36% 
Prostatectomy 154 21% 
Urethroplasty 113 16% 
Nephrectomy 61 8% 
Hyospadias repair 43 5.9% 




Total 726 100 
DVU (Direct Vision Urethrotomy), TCB ( Tru-
Cut Biopsy of prostate), BSO(Bilateral Sub 
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Table 2: levels of contamination in urological surgeries and antibiotic use  




  Yes No Total 
Clean 265(74.6%) 90(25.4%) 355(100%) 
Clean 
contaminated 
324(87.4%) 47(12.6%) 371(100%) 
Contaminated 
   
Dirty 
   



















































DVU+CYSTOSCOPY 56.3% 6.4% 3.3% 32.8% 1.2% 
URETHROPLASTY 51% 8.6% 7.4% 28.4% 4.6% 
PROSTATECTOMY 56.5% 6.3% 14.2% 21.7% 1.3% 
NEPHRECTOMY 10% 8% 3.6% 75.6% 2.8% 
HYPOSPADIAS REPAIR 54.3% 12.6% 2.6% 28.7% 1.9% 
OTHER( TCB,BSO,SPC, 
CYSTECTOMY) 
48.4% 7.2% 4.8% 38% 1.8% 
Average percentage 46.1% 8.2% 6% 37.5% 2.3% 
